Yang Huang

Yang Huang

Auto-generated profile, based on publicly available information

Yang Huang

State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Sciences, School of Public Health, Xiamen University, Xiamen 361102, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2021 in Cell Host & Microbe
Verified
Journal Article
Closed access
LXLongfa Xu
Longfa Xu
QZQingbing Zheng
Qingbing Zheng
RZRui Zhu
Rui Zhu
ZYZhichao Yin
Zhichao Yin
HYHai Yu
Hai Yu
NXNingshao Xia
Ningshao Xia

1 February 2020 in Cell Host & Microbe
Verified
Journal Article
Closed access
MHMaozhou He
Maozhou He
LXLongfa Xu
Longfa Xu
QZQingbing Zheng
Qingbing Zheng
RZRui Zhu
Rui Zhu
ZYZhichao Yin
Zhichao Yin
NXNingshao Xia
Ningshao Xia


28 November 2021 in Viruses
Verified
Journal Article
Open access
PDF file
JHJunping Hong
Junping Hong
DWDongmei Wei
Dongmei Wei
QWQian Wu
Qian Wu
LZLing Zhong
Ling Zhong
KCKaiyun Chen
Kaiyun Chen
YCYixin Chen
Yixin Chen
Epstein–Barr virus (EBV) is the first reported oncogenic virus and infects more than 90% of adults worldwide. EBV can establish a latent infection in B lymphocytes which is essential for persistence and transmission. Glycoprotein gp42 is an indispensable member of the triggering complex for EBV entry into a B cell. The N-terminal region of gp42 plays a key role in binding to gH/gL and triggering subsequent membrane fusion. However, no antibody has been reported to recognize this region and the immunogenicity of gp42 N-domain remains unknown. In the present study, we have generated a panel of nine mAbs against the gp42 N-terminal region (six mAbs to gp42-44-61aa and three mAbs to gp42-67-81aa). These mAbs show excellent binding activity and recognize different key residues locating on the gp42 N-domain. Among the nine mAbs, 4H7, 4H8 and 11G10 cross-react with rhLCV-gp42 while other mAbs specifically recognize EBV-gp42. Our newly obtained mAbs provide a useful tool for investigating the gp42 function and viral infection mechanism of γ-Herpesvirus. Furthermore, we assess the immunogenicity of the gp42 N-terminal region using the HBc149 particle as a carrier protein. The chimeric VLPs can induce high antibody titers and elicit neutralizing humoral responses to block EBV infection. More rational and effective designs are required to promote the gp42-N terminal region to become an epitope-based vaccine.

20 July 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
XZXiang Zhou
Xiang Zhou
YLYong Liu
Yong Liu
YHYang Huang
Yang Huang
SZShuiBo Zhu
ShuiBo Zhu
JZJian Zhu
Jian Zhu
RWRongping Wang
Rongping Wang
Hypertonic saline (HS) attenuates cerebral edema, improves microcirculation perfusion and alleviates inflammation. However, whether the beneficial effect of HS on neurological function after cardiopulmonary resuscitation (CPR) in rat model of asphyxial cardiac arrest (CA) is mediated via attenuating apoptosis of neurons is not known. We studied the neuroprotective effect of HS in rats after CA and CPR, and explored the likely underlying mechanisms. Animals were randomly assigned to 4 equal groups (n = 15 each) according to the different infusions administered during resuscitation: control (C), normal saline (NS), hypertonic saline (HS), and hydroxyethyl starch (HES) groups. NDS at 12, 24, 48 and 72 h post-ROSC in the HS group were significantly higher than those in the NS and HES groups. Western blot analysis demonstrated a significant increase in Bcl-2 expression in HS, as compared to that in the NS and HES groups. However, Bax and Caspase-3 expressions in HS were significantly lower than that in the NS and HES groups. The apoptosis rate in HS was significantly lower than that in the NS and HES groups, suggesting HS treatment during resuscitation could effectively suppress neuronal cell apoptosis in hippocampal CA1 post-ROSC and improve neuronal function.

23 May 2023 in IEEE/ACM Transactions on Computational Biology and Bioinformatics
Verified
Journal Article
Closed access
ZCZihao Chen
Zihao Chen
NLNan Liu
Nan Liu
YHYang Huang
Yang Huang
XMXiaoping Min
Xiaoping Min
XZXIANGXIANG ZENG
XIANGXIANG ZENG
NXNingshao Xia
Ningshao Xia
Protein-protein interactions (PPIs) play essential roles in many vital movements and the determination of protein complex structure is helpful to discover the mechanism of PPI. Protein-protein docking is being developed to model the structure of the protein. However, there is still a challenge to selecting the near-native decoys generated by protein-protein docking. Here, we propose a docking evaluation method using 3D point cloud neural network named PointDE. PointDE transforms protein structure to the point cloud. Using the state-of-the-art point cloud network architecture and a novel grouping mechanism, PointDE can capture the geometries of the point cloud and learn the interaction information from the protein interface. On public datasets, PointDE surpasses the state-of-the-art method using deep learning. To further explore the ability of our method in different types of protein structures, we developed a new dataset generated by high-quality antibody-antigen complexes. The result in this antibody-antigen dataset shows the strong performance of PointDE, which will be helpful for the understanding of PPI mechanisms.